Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Pascal SEVE"'
Autor:
Charlene Desaintjean, Kaïs Ahmad, Julie Traclet, Mathieu Gerfaud-Valentin, Cecile-Audrey Durel, Jean-Charles Glerant, Arnaud Hot, François Lestelle, Sabine Mainbourg, Mouhamad Nasser, Pascal Seve, Ségolène Turquier, Gilles Devouassoux, Vincent Cottin
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionAsthma associated with eosinophilic granulomatosis with polyangiitis (EGPA) is often severe and corticosteroid-dependent, leading to significant morbidity. Mepolizumab and benralizumab are humanized monoclonal antibodies targeting interle
Externí odkaz:
https://doaj.org/article/e0b0b13aec77423fb4700b67df99367f
Autor:
Robin Jacquot, Maurine Jouret, Mathieu Gerfaud Valentin, Maël Richard, Yvan Jamilloux, Florent Rousset, Jean-François Emile, Julien Haroche, Lars Steinmüller, Franck Zekre, Alice Phan, Alexandre Belot, Pascal Seve
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
H syndrome is a rare autosomal recessive genetic disorder characterized by the following clinical features: cutaneous hyperpigmentation, hypertrichosis, hepatosplenomegaly, heart anomalies, hearing loss, hypogonadism, short stature, hallux valgus, hy
Externí odkaz:
https://doaj.org/article/2cac38a4c3bb4e77afbf34368aeb7c5a
Autor:
Alain Calender, Pierre Antoine Rollat Farnier, Adrien Buisson, Stéphane Pinson, Abderrazzaq Bentaher, Serge Lebecque, Harriet Corvol, Rola Abou Taam, Véronique Houdouin, Claire Bardel, Pascal Roy, Gilles Devouassoux, Vincent Cottin, Pascal Seve, Jean-François Bernaudin, Clarice X. Lim, Thomas Weichhart, Dominique Valeyre, Yves Pacheco, Annick Clement, Nadia Nathan, in the frame of GSF (Groupe Sarcoïdose France)
Publikováno v:
BMC Medical Genomics, Vol 11, Iss 1, Pp 1-19 (2018)
Abstract Background Sarcoidosis (OMIM 181000) is a multi-systemic granulomatous disorder of unknown origin. Despite multiple genome-wide association (GWAS) studies, no major pathogenic pathways have been identified to date. To find out relevant sarco
Externí odkaz:
https://doaj.org/article/4056fb49f80d4471b504aa3aa69fdf58
Autor:
Nicolas Penel, Sylvie Negrier, Isabelle Ray-Coquard, Charles Ferte, Patrick Devos, Antoine Hollebecque, Michael B Sawyer, Antoine Adenis, Pascal Seve
Publikováno v:
PLoS ONE, Vol 4, Iss 8, p e6483 (2009)
BackgroundWe have investigated predictors of 90-day-mortality in a large cohort of non-specific cancer of unknown primary patients.MethodsPredictors have been identified by univariate and then logistic regression analysis in a single-center cohort co
Externí odkaz:
https://doaj.org/article/2a93c6567a9443f396b3d2a0cf75cf43
Autor:
Nicolas Fournier, Yvan Jamilloux, Mathieu Gerfaud-Valentin, Nathalie Streichenberger, Sandra Vukusic, Romain Marignier, Géraldine Androdias, Pascal Seve
Publikováno v:
European Neurology.
Introduction: The definite diagnosis of neurosarcoidosis is challenging since it requires a compatible histology of the nervous system. When neurosarcoidosis is suspected, other systemic manifestations are investigated to confirm the diagnosis. A min
Autor:
Hippolyte LEQUAIN, Olivier BRUNET, Julien SEILLER, Amro ABUKHASHBAH, Carole BURILLON, Emmanuelle VIGNOT, Pascal SEVE
Background: Whipple's disease is a rare infectious systemic condition caused by Tropheryma whipplei which, can involve several organs such as the gastrointestinal tract, joins, skin, central nervous system, and eyes. Because of its non-specific sympt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::423e5a9ab13c5cc890176083cb40f840
https://doi.org/10.21203/rs.3.rs-2251552/v1
https://doi.org/10.21203/rs.3.rs-2251552/v1
Publikováno v:
The Lancet. 401:1691
Autor:
Pascal Seve, Fabien Craighero
Publikováno v:
Revue Neurologique. 179:S180
Autor:
Clémence, Thery-Casari, Yvan, Jamilloux, Diane, Bouvry, Catherine, Chapelon-Abric, Alicia, Marquet, Philip, Bielefeld, Nicolas, Schleinitz, Sandra, Vukusic, Nicolas, Girszyn, Olivier, Fain, Fabrice, Bonnet, Dominique, Valeyre, Pascal, Seve
Publikováno v:
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases
Background: Tumor necrosis factor (TNF) antagonists have been reported as an efficient third-line therapy for sarcoidosis but there is no data regarding patients who do not respond to this treatment. Objective: To report the characteristics, the outc
Autor:
Maxime, Nhari, Amina, Rezkallah, Matthieu, Gerfaud-Valentin, Pascal, Seve, Laurent, Kodjikian, Philippe, Denis, Thibaud, Mathis
Publikováno v:
Ocular Immunology and Inflammation
Ocular Immunology and Inflammation, 2022, ⟨10.1080/09273948.2021.2025252⟩
Ocular Immunology and Inflammation, 2022, ⟨10.1080/09273948.2021.2025252⟩
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ba2856f6be605d3a18429fd90cf2dc8
https://hal.science/hal-03763029
https://hal.science/hal-03763029